Literature DB >> 32213334

The forgotten tale of Brazilian phage therapy.

Gabriel Magno de Freitas Almeida1, Lotta-Riina Sundberg2.   

Abstract

The use of bacteriophages to treat bacterial infections (known as phage therapy) is considered a possible solution to the antimicrobial resistance crisis. However, phage therapy is not a new concept. The discovery of phages in the early 20th century was closely tied to clinical practice, and phage therapy quickly spread around the world. The use of phage therapy in South America in the previous century is still shrouded in mystery and has been mentioned only briefly in recent scientific literature. Research on Brazilian reference collections of medical texts showed that Brazil was an important, but so far little-known, player of phage therapy, uncovering interesting priority claims and missing pieces of phage therapy history. Of note, there is the widespread use of phages against bacillary dysentery and staphylococcal infections, with José da Costa Cruz from the Oswaldo Cruz Institute (Rio de Janeiro, Brazil) as Brazil's leading expert and pioneer. This Historical Review about historical phage use in Brazil fills the gaps in our knowledge about the so-called golden years of phage therapy, providing information about successful experiences that can be useful against dangerous pathogens in our time.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32213334     DOI: 10.1016/S1473-3099(20)30060-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  4 in total

Review 1.  The Safety and Efficacy of Phage Therapy for Bone and Joint Infections: A Systematic Review.

Authors:  Alex L Clarke; Steven De Soir; Joshua D Jones
Journal:  Antibiotics (Basel)       Date:  2020-11-10

2.  Mycelia-Assisted Isolation of Non-Host Bacteria Able to Co-Transport Phages.

Authors:  Xin You; Niclas Klose; René Kallies; Hauke Harms; Antonis Chatzinotas; Lukas Y Wick
Journal:  Viruses       Date:  2022-01-20       Impact factor: 5.048

Review 3.  Clinical utilization of bacteriophages: a new perspective to combat the antimicrobial resistance in Brazil.

Authors:  Willames M B S Martins; Mark A Toleman; Ana C Gales
Journal:  Braz J Infect Dis       Date:  2020-05-15       Impact factor: 3.257

4.  Prevalence of genetically similar Flavobacterium columnare phages across aquaculture environments reveals a strong potential for pathogen control.

Authors:  Anniina Runtuvuori-Salmela; Heidi M T Kunttu; Elina Laanto; Gabriel M F Almeida; Kati Mäkelä; Mathias Middelboe; Lotta-Riina Sundberg
Journal:  Environ Microbiol       Date:  2022-01-28       Impact factor: 5.476

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.